TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts18182222
Avg. Estimate0.530.592.492.61
Low estimate0.470.542.372.35
High estimate0.610.642.612.77
Year ago EPS0.60.582.42.49
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts15152020
Avg. Estimate3.96B4.08B16.79B16.97B
Low estimate3.81B3.85B16.27B16.32B
High estimate4.15B4.2B17.78B18.34B
Year ago sales4.34B4.26B16.89B16.79B
Sales growth (year/est)-8.80%-4.30%-0.60%1.00%
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS0.570.590.610.59
Actual EPS0.60.580.620.76
Difference0.03-0.010.010.17
Surprise %5.30%-1.70%1.60%28.80%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate0.530.592.492.61
7 days ago0.540.592.512.62
30 days ago0.540.592.512.63
60 days ago0.580.612.442.62
90 days ago0.590.612.452.62
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesTEVAIndustrySectorS&P 500
Current qtr.-11.70%N/AN/AN/A
Next qtr.1.70%N/AN/AN/A
Current year3.80%N/AN/AN/A
Next year4.80%N/AN/AN/A
Next 5 years (per annum)3.20%N/AN/AN/A
Past 5 years (per annum)-16.30%N/AN/AN/A